IO Biotech, Inc.
Develops dual-action, off-the-shelf therapeutic cancer vaccines for solid tumors.
IOBT | NDAQ
Overview
Corporate Details
- ISIN(s):
- US4497781090
- LEI:
- Country:
- United States of America
- Address:
- OLE MAALOES VEH 3, 2200 COPENHAGEN
- Website:
- https://www.iobiotech.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
IO Biotech, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, immune-modulating therapeutic cancer vaccines. The company pioneers a dual-action, off-the-shelf approach based on its proprietary T-win technology platform, which is designed to activate T cells to target and eliminate cancer cells by overcoming tumor immune escape mechanisms. Its lead product candidate, IO102-IO103, is in clinical development for the treatment of various solid tumors, including melanoma. IO Biotech aims to improve outcomes for cancer patients through its innovative immunotherapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all IO Biotech, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for IO Biotech, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for IO Biotech, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
